MedTrace Logo

Role of Salbutamol in the Management of Transient Tachypnea of the New Born

NCT06921291 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-04-10

No results posted yet for this study

Summary

Role of Salbutamol in the management of transient tachypnea of the new born

Conditions

  • TTN

Interventions

DRUG

Salbutamol (Ventolin®)

Randomized controlled trials

Sponsors & Collaborators

  • Khyber Teaching Hospital

    lead OTHER

Principal Investigators

  • Sabahat Amir, MBBS FCPS · Department of Pediatrics Khyber Teaching Hospital Peshawar, KPK , Pakistan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06921291 on ClinicalTrials.gov